< 首頁 - 合作夥伴 - 臨床試驗受託機構 - 益欣國際醫藥科技股份有限公司
臨床試驗受託機構

益欣國際醫藥科技股份有限公司 EPS International Taiwan

益欣國際醫藥科技股份有限公司

卓越成果

EPS International (EPSI) is the global arm of the EPS Group which prides itself on being the largest CRO in Japan and amongst the top five in Asia, making it the ideal partner for companies wishing to establish or extend its operations in this fastest growing region of the worldwide pharmaceutical market.

EPS international provide a wide range of drug development solution from clinical to commercial including Contract Research organization(CRO), Site management organization(SMO). Contract Sales organization(CSO), and other related service for Pharmaceutical and medical device development in Asia Pacific.

Disease Area/ Indication

phase I-III

Remarks

Lysosomal acid lipase deficiency

III

 

Pulmonary Arterial Hypertension

III

 

Myopia

II

 

Antibiotic

I

 

Cancer (Metastatic)

I

 

Oral contraception in females

I

 

Cancer (Breast)

III

 

Acne

III

 

Cutaneous T-Cell Lymphoma (CTCL)

II

 

Osteoporosis

I

 

Hepatocellular Carcinoma

I

 

Pompe Disease

III

 

Cholera

III

 

Non-Hodgkins Lymphoma

III

 

Hepatitis C

III

 

Cancer (Breast)

I

 

Autism

IV

 

Hepatocellular Carcinoma or Tumor Mestastatic to the liver

I

 

Non-Small Cell Lung Cancer

III

 

Nonalcoholic steatohepatitis(NASH)

III

 

Orthopaedics - Open Bone fracture

I

 

Cancer (Lung)

II

 

Cancer (Breast)

II

 

Cerebral Vascular Accident (stroke)

II

 

Sjogren’s Syndrom

I

 

Diarrhioea

III

 

Cancer (Pancreas)

III

 

Hepatocellular Carcinoma

III

 

Hyperlipidemia

III

 

Schizophrenia

III

 

Cerebral Vascular Accident (stroke)

III

 

Cancer (Breast)

III

 

Infertility

I

 

Short bowel syndrome

III

 

Macular oedema

IV

 

Growth Hormone Deficiency

III

 

Cancer (Stomach)

III

 

Cancer (Esophagus)

III

 

Tourette Syndrome (TS)

III

 

Sarcoma (Tissue)

II/III

 

Acute Unilateral Vestibulopathy (AUV)

II/III

 

Systemic Lupus Erythematosus (SLE)

III

 

Primary Axillary Hyperhidrosis

II

 

Cancer (Head & Neck)

III

 

Hyperkalemia

III

 

Pulmonary Arterial Hypertension

IV

 

Acute Phase Adenoviral-Induced Epidemic Keratoconjunctivitis

II

 

Alpha1-antitrypsin deficiency

III

 

Eye disorders

III

 

Relapsed or refractory peripheral T-cell lymphoma

II

 

Solid tumor

I

 

專長服務項目

  • Clinical Development & Project Management
  • Data Management and statistical Analysis
  • Regulatory Affairs
  • Medical Writing
  • Quality Assurance

提供實驗室服務

國際認證

財團法人醫藥品查驗中心 T : 請至聯絡我們留言